Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245851772881
Publisher
SAGE Publications
Online
2017-08-31
DOI
10.1177/1352458517728811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
- (2017) Luanne M. Metz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome
- (2016) Maria Laura Bertolaccini et al. JOURNAL OF AUTOIMMUNITY
- Complement is activated in progressive multiple sclerosis cortical grey matter lesions
- (2016) Lewis M. Watkins et al. Journal of Neuroinflammation
- An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination
- (2016) Michael B. Keough et al. Nature Communications
- Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis
- (2015) Mika Komori et al. ANNALS OF NEUROLOGY
- Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
- (2015) Brit Fitzner et al. AUTOIMMUNITY REVIEWS
- Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration
- (2015) Rebecca Scholz et al. Journal of Neuroinflammation
- Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis
- (2015) Marcus W. Koch et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Multiple sclerosis—a quiet revolution
- (2015) Richard M. Ransohoff et al. Nature Reviews Neurology
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
- (2014) Manuel A. Friese et al. Nature Reviews Neurology
- Iron and neurodegeneration in the multiple sclerosis brain
- (2013) Simon Hametner et al. ANNALS OF NEUROLOGY
- Reduction of microglial activity in a model of multiple sclerosis by dipyridamole
- (2013) Scott Sloka et al. Journal of Neuroinflammation
- Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
- (2013) Jeppe Romme Christensen et al. PLoS One
- Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis
- (2013) David W Hampton et al. Acta Neuropathologica Communications
- NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury
- (2012) Marie T. Fischer et al. BRAIN
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis
- (2011) Sarah Al-Izki et al. Multiple Sclerosis Journal
- Matrix Metalloproteinase-12 Deficiency Worsens Relapsing-Remitting Experimental Autoimmune Encephalomyelitis in Association with Cytokine and Chemokine Dysregulation
- (2009) Angelika Goncalves DaSilva et al. AMERICAN JOURNAL OF PATHOLOGY
- Different methods for control and comparison of the antioxidant properties of vegetables
- (2009) Milan Číž et al. FOOD CONTROL
- Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
- (2009) LM Metz et al. Multiple Sclerosis Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now